Wellnex Life Limited (ASX:WNX)

The next generation of wellness your life deserves.

About Us

Wellnex is an ASX-listed owner and developer of healthcare brands and IP that generated ~$28 million revenue during FY23 (unaudited) and is expecting to grow to $47 million during FY24B.

Wellnex has executed a binding agreement to undertake a transformative acquisition of Pain Away, the #2 brand in the topical pain relief category in Australia.

Post-completion, the merged group is expected to generate revenue of $62.9 million and EBITDA of $9.0 million during FY24B.

Company Overview

Founded with a mission to deliver health and vitality solutions, Wellnex Life provides high-quality, innovative wellness products. The company operates in the fast-growing consumer health sector, focusing on over-the-counter medicines, supplements, and functional foods.

Wellnex Life’s vertically integrated operations include in-house product development and partnerships with licensing and distribution networks. This enables the company to respond quickly to market trends and deliver new products to consumers.

As part of its growth strategy, Wellnex is expanding its presence in international markets, including Europe and the Middle East. With its innovative product pipeline and established retail partnerships, Wellnex Life is poised for sustained growth.

Board & Management

George Karafotias

George Karafotias

Chief Executive Officer

Jeffrey Yeh

Jeffrey Yeh

Non Executive Director

Zack Bozinovski

Zack Bozinovski

Chief Strategy Officer

Eric Jiang

Eric Jiang

Non-Executive Director

Andrew Vidler

Andrew Vidler

Non-Executive Director

Wellnex Life Limited

Follow Wellnex Life Limited

By submitting your information below you can keep up to date with their relevant news and announcements.

Fields marked with * are required.

Name(Required)

Cancel